Reporting from: – Gastrointestinal Cancers Symposium, January 27-29, 2005, Hollywood, Florida In this edition: Bruce Giantonio and Robert Mayer discuss the Eastern Cooperative Oncology Group stu
Reporting from:
– Gastrointestinal Cancers Symposium, January 27-29, 2005, Hollywood, Florida
In this edition:
Bruce Giantonio and Robert Mayer discuss the Eastern Cooperative Oncology Group study in which bevacizumab was added to an oxaliplatinbased regimen for the management of advanced colorectal cancer previously treated with chemotherapy.
Heinz-Josef Lenz reports on an investigation showing single-agent cetuximab to be effective in the treatment of advanced colorectal cancer that is refractory to all of the usual cytotoxic drugs.
Malcolm Moore’s trial involving patients with advanced pancreatic cancer, in which gemcitabine standard therapy has been supplemented with erlotinib (a drug targeting the epidermal growth factor pathway), has shown a small but definite improvement in survival and disease control. Robert Mayer discusses the results.
Daniel Haller explains how his ONCOSURGE decision-making system for the treatment of colorectal cancer metastases can be applied to potentially extend life and even cure patients by helping clinicians decide which strategies to use in each particular clinical situation.